CME Group Inc.
02/02/2026 | Press release | Distributed by Public on 02/02/2026 08:31
Regulation FD Disclosure (Form 8-K)
| Item 7.01 | Regulation FD Disclosure. |
On February 2, 2026, CME Group Inc. communicated pricing changes to its clients via Special Executive Report 9676. A copy of this notice has been posted to the Company's website.
The information furnished under Item 7.01 of this report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. The information furnished under Item 7.01 of this report shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.
CME Group Inc. published this content on February 02, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on February 02, 2026 at 14:32 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]